Concepedia

Publication | Open Access

First‐in‐human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection

DOIFull Paper Access

41

Citations

20

References

2020

Year

Mohamed Farouk Chughlay, Emilie Rossignol, Cristina Donini, Myriam El Gaaloul, Ulrike Lorch, Simon Coates, Grant Langdon, Tim Hammond, Jörg J. Möhrle, Stephan Chalon
British Journal of Clinical Pharmacology

Abstract

P218 displayed favourable safety, tolerability and pharmacokinetics. In view of its short half-life, a long-acting formulation will be needed for malaria chemoprotection.

References

YearCitations

Page 1